Journals / Türk Uyku Tıbbı Dergisi / 2021 / Cilt: 8 - Sayı: 3

Fluoxetine-Associated Sleep Disorders-Report of Two Cases and Literature Review

Fluoksetin Kaynaklı Uyku Bozuklukları: İki Olgu Sunumu ve Literatür Derlemesi

Pages
13–16
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Sleep disorder occurring as secondary to medication has been ignored because it has eluded the clinicians.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Narcolepsy is a condition characterised by excessive daytime sleepiness, cataplexy, hypnogogic hallucination and sleep paralysis.
📊
Key Findings & Data:Sleep-related eating disorder (SRED) is a parasomnia that occurs while sleeping and manifests itself as paroxysmal episodes of involuntary eating and/or drinking.
💡
Conclusion & Impact:Sleep disorder occurring as secondary to medication has been ignored because it has eluded the clinicians.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Narcolepsy is a condition characterised by excessive daytime sleepiness, cataplexy, hypnogogic hallucination and sleep paralysis. Sleep-related eating disorder (SRED) is a parasomnia that occurs while sleeping and manifests itself as paroxysmal episodes of involuntary eating and/or drinking. Both sleep disorders often occur as primary conditions. Sleep disorders secondary to medical treatment less often occur. This report presents the case of a patient with narcolepsy and another with SRED as a result of anamnesis and polysomnography. These sleep disorders are due to recently initiated fluoxetine treatment. Sleep disorder occurring as secondary to medication has been ignored because it has eluded the clinicians.

Özet

Narkolepsi; gündüz aşırı uyku hali, katapleksi, hipnogojik halüsinasyon, uyku paralizisi ile karakterize bir hastalıktır. Uyku ile ilgili yeme bozukluğu (SRED); uyku sırasında ortaya çıkan, paroksismal, istem dışı yemek yeme ve/veya içme epizodları ile seyreden bir parasomni tablosudur. Her iki uyku bozukluğu da sıklıkla primer olarak ortaya çıkmaktadır. Medikal tedaviye sekonder olarak ortaya çıkan olgu daha nadirdir. Bizim sunduğumuz yazıda, anamnez ve polisomnografi incelemesi sonucunda bir hastada narkolepsi, diğer hastada SRED tanıları düşünüldü ve bu durumların yeni başlanan fluoksetin tedavisine sekonder olduğu kararına varıldı. İlaca sekonder oluşan uyku bozukluğu klinisyenler ta

🔖

Cite This Article

DEMİR, A. B., LEBA, L. K. (2022). Fluoxetine-Associated Sleep Disorders-Report of Two Cases and Literature Review. Türk Uyku Tıbbı Dergisi, Cilt: 8 - Sayı: 3, 13–16. https://ajindex.com/articles/643263

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Thannickal TC, Moore RY, Nienhuis R, Ramanathan L, Gulyani S, Aldrich M, Cornford M, Siegel JM. Reduced number of hypocretin neurons in human narcolepsy. Neuron 2000;27:469-74
  2. Dauvilliers Y, Arnulf I, Mignot E. Narcolepsy with cataplexy. Lancet 2007;369:499-511
  3. Burgess CR, Scammell TE. Narcolepsy: neural mechanisms of sleepiness and cataplexy. J Neurosci 2012;32:12305-11
  4. Sateia MJ. International classification of sleep disorders-third edition: highlights and modifications. Chest 2014;146:1387-94
  5. Broughton RJ, Shimizu T. Sleep-related violence: a medical and forensic challenge. Sleep 1995;18:727-30
  6. Pressman MR. Factors that predispose, prime and precipitate NREM parasomnias in adults: Clinical and forensic implications. Sleep Med Rev 2007;11:5-30
  7. Vinai P, Ferri R, Ferini-Strambi L, Cardetti S, Anelli M, Vallauri P, Ferrato N, Zucconi M, Carpegna G, Manconİ M. Defining the borders between Sleep-Related Eating Disorder and Night Eating Syndrome. Sleep Med 2012;13:686-90
  8. Wichniak A, Wierzbicka A, Jernajczyk W. Sleep and Antidepressant Treatment. Curr Pharm Des 2012;18:5802-17
  9. Thompson C. Onset of action of antidepressants: results of different analyses. Hum Psychopharmacol 2002;17(Suppl 1):S27-32
  10. Wilson S, Argyropoulos S. Antidepressants and sleep. Drugs 2005;65:927-47
  11. Stoyek MR, Jonz MG, Smith FM, Croll RP. Distribution and chronotropic effects of serotonin in the zebrafish heart. Auton Neurosci 2017;206:43-50
  12. Poryazova R, Siccoli M, Werth E, Bassetti CL. Unusually prolonged rebound cataplexy after withdrawal of fluoxetine. Neurology 2005;65:967-8
  13. Golub MS, Hogrefe CE. Sleep disturbance as detected by actigraphy in pre-pubertal juvenile monkeys receiving therapeutic doses of fluoxetine. Neurotoxicol Teratol 2016;55:1-7
  14. Çolak Sivri R, Akça ÖF. Buspirone in the Treatment of FluoxetineInduced Sleep Bruxism. J Child Adolesc Psychopharmacol 2016;26:762-3
  15. Akbaş B, Bilgiç A. Fluoxetine-Induced Sleep Bruxism Rapidly Treated With Once-Nightly Dosing of Buspirone in a 6-Year-Old Girl. Clin Neuropharmacol 2018;41:197-8.